46
Views
15
CrossRef citations to date
0
Altmetric
Original Article

The Pharmacology of Ototoxic Drugs

Pages 81-93 | Published online: 12 Oct 2009

References

  • Albiero L., Bamonte F., Ongini E., Parravicini L. Comparison of neuromuscular effects and acute toxicity of some aminoglycoside antibiotics. Archives Internationales de Pharmacodynamie et de Thérapie 1978; 233: 343–350
  • Albiero L., Ongini E., Parravicini L. The neuromuscular blocking activity of a new aminoglycoside antibiotic netilmicin sulphate (SCH 20569). European Journal of Pharmacology 1978; 50: 1–7
  • Avasthi P. S., Evan A. P., Huser J. W., Luft F. C. Effect of gentamicin on glomerular ultra-structure. Journal of Laboratory and Clinical Medicine 1981; 98: 444–454
  • Barza M., Lauermann M. Why monitor serum levels of gentamicin?. Clinical Pharmacokinetics 1978; 3: 202–215
  • Barza M., Lauermann M. W., Tally F. P., Gorbach S. L. Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity. Antimicrobial Agents and Chemotherapy 1980; 17: 707–714
  • Baylis C., Rennke H. R., Brenner B. M. Mechanisms of the defect in glomerular ultrafiltration associated with gentamicin administration. Kidney International 1977; 12: 344–353
  • Bellucci R. J., Wolff D. Tissue reaction following reconstruction of the oval window in experimental animals. Annals of Otology, Rhinology and Laryngology 1960; 69: 517–539
  • Beyer K. H., Baer J. E., Michaelson J. K., Russo H. F. Renotropic characteristics of etha-crynic acid: a phenoxyacetic saluretic diuretic agent. Journal of Pharmacology and Experimental Therapeutics 1965; 147: 1–22
  • Bicknell P. G. Sensorineural deafness following myringoplasty operations. Journal of Laryngology and Otology 1971; 85: 957–961
  • Bock B. V., Edelstein P. H., Meyer R. D. Prospective comparative study of efficacy and toxicity of netilmicin and amikacin. Antimicrobial Agents and Chemotherapy 1980; 17: 217–225
  • Bosher S. K. The nature of the negative endo-cochlear potentials produced by anoxia and etha-crynic acid in the rat and guinea-pig. Journal of Physiology 1979; 293: 329–345
  • Bosher S. K. The nature of the ototoxic actions of ethacrynic acid upon the mammalian endolymph system. I. Functional aspects. Acta Otolaryngologies 1980a; 89: 407–418
  • Bosher S. K. The nature of the ototoxic actions of ethacrynic acid upon the mammalian endolymph system. II. Structural-functional correlates in the stria vascularis. Acta Otolaryngo-logica 1980b; 90: 40–54
  • Boston Collaborative Drug Surveillance Program. Drug-induced deafness. Journal of the American Medical Association 1973; 224: 515–516
  • Bourke E. Frusemide, bumetanide and ototoxicity. Lancet 1976; 1: 917–918
  • Brown R. D. Comparison of the cochlear toxicity of sodium ethacrynate, furosemide, and the cysteine adduct of sodium ethacrynate in cats. Toxicology and Applied Pharmacology 1975a; 31: 270–282
  • Brown R. D. Cochlear N, depression produced by the new ‘loop’ diuretic, bumetanide, in cats. Neuropharmacology 1975b; 14: 547–553
  • Brown R. D., Feldman A. M. Pharmacology of hearing and ototoxicity. Annual Reviews of Pharmacology and Toxicology 1978; 18: 233–252
  • Brown R. D., McElwee T. W., Jr. Effects of intra-arterially and intravenously administered ethacrynic acid and furosemide on chochlear N, in cats. Toxicology and Applied Pharmacology 1972; 22: 589–594
  • Brummett R. E. Drug-induced ototoxicity. Drugs 1980; 19: 412–428
  • Brummett R. E., Fox K. E., Bendrick T. W., Himes D. L. Ototoxicity of tobramycin, genta-micin, amikacin and sisomicin in the guinea pig. Journal of Antimicrobial Chemotherapy 1978a; 4(Supplement A)73–83
  • Brummett R. E., Fox K. E., Brown R. T., Himes D. L. Comparative ototoxic liability of netilmicin and gentamicin. Archives of Otolaryngology 1978b; 104: 579–584
  • Brummett R., Smith C. A., Ueno Y., Cameron S., Richter R. The delayed effects of ethacrynic acid on the stria vascularis of the guinea pig. Acta Otolaryngologica 1977; 83: 98–112
  • Brummett R. E., Traynor J., Brown R., Himes D. Cochlear damage resulting from kanamycin and furosemide. Acta Otolaryngologica 1975; 80: 86–92
  • Caputy A. J., Kim Y. I., Sanders D. B. The neuromuscular blocking effects of therapeutic concentrations of various antibiotics on normal rat skeletal muscle: a quantitative comparison. Journal of Pharmacology and Experimental Therapeutics 1981; 217: 369–378
  • Crifo S. Ototoxicity of sodium ethacrynate in the guinea-pig. Archives of Oto-rhino-laryngology 1973; 206: 27–38
  • Cummings C. W. Experimental observations on the ototoxicity of nitrogen mustard. Laryngoscope 1968; 78: 530–538
  • ĎAngelo E. P., Patterson W. C., Morrow R. C. Chloramphenicol: topical application to the middle ear. Archives of Otolaryngology 1967; 85: 682–684
  • Davey P. G., Gonda I., Harpur E. S., Scott D. K. Review of recent studies on control of aminoglycoside antibiotic therapy. Journal of Clinical and Hospital Pharmacy 1980; 5: 175–195
  • Davey P. G., Jabeen F., Harpur E. S., Shenoi P. M., Geddes A. M. The use of pure-tone audiometry in the assessment of gentamicin auditory toxicity. British Journal of Audiology 1982; 16: 151–154
  • Dewar W. A., Mann H. M. Chloroquine in lupus erythematosus. Lancet 1954; 1: 780–781
  • Ernstson S. Ethacrynic acid-induced hearing loss in guinea pigs. Acta Otolaryngologica 1972; 73: 476–483
  • Fee W. E., Vierra V., Lathrop G. R. Clinical evaluation of aminoglycoside toxicity. tobramycin versus gentamicin, a preliminary report. Journal of Antimicrobial Chemotherapy 1978; 4(Supplement A)31–36
  • Fleischman R. W., Stadnicki S. W., Ethier M. F., Schaeppi V. Ototoxicity of cis-dichlorodiammeplatinum (II) in the guinea pig. Toxicology and Applied Pharmacology 1975; 33: 320–332
  • Gallagher K. L., Jones J. K. Furosemide-induced ototoxicity. Annals of Internal Medicine 1979; 91: 744–745
  • Gargye A. K., Dutta D. V. Nerve deafness following Chloromycetin therapy. Indian Journal of Pediatrics 1959; 26: 265–266
  • Gonda I., Harpur E. S. Accumulation in the peripheral compartment of a linear two-compartment open model. Journal of Pharmacokinetics andBiopharmaceutics 1980; 8: 99–104
  • Hanzelik E., Peppercorn M. Deafness after ethacrynic acid. Lancet 1969; 1: 416
  • Harpur E. S. Neomycin and deafness. Pharmaceutical Journal 1977; 218: 494–495
  • Harpur E. S., Gonda I. Analysis of the pharmacokinetics of ribostamycin in serum and perilymph of guinea pigs after single and multiple doses. British Journal of Audiology 1982; 16: 95–99
  • Hart C. W., Naunton R. F. The ototoxicity of chloroquine phosphate. Archives of Otolaryngology 1964; 80: 407–412
  • Hawkins J. E., Jr. Antibiotics and the inner ear. Transactions of the American Academy of Ophthalmology and Otolaryngology 1959; 63: 206–218
  • Hawkins J. E., Jr. Ototoxic mechanisms. Audiology 1973; 12: 383–393
  • Hayes D. H., Cvitkovic E., Golbey R. B., Scheiner E., Helson L., Krakoff I. H. High-dose cis-platinum diamminedichloride. Amelioration of renal toxicity by mannitol diuresis. Cancer 1977; 39: 1372–1381
  • Hennebert D., Fernandez C. Ototoxicity of quinine in experimental animals. Archives of Otolaryngology 1959; 70: 321–333
  • vonHoff D. D., Schilsky R., Reichert C. M., Reddick R. L., Rozencweig M., Young R. C., Muggia F. M. Toxic effects of c/s-dichloro-diammineplatinum (II) in man. Cancer Treatment Reports 1979; 63: 1527–1531
  • Hottendorf G. H., Barnett D., Gorden L. L., Christensen E. F., Madissoo H. Non-parallel nephrotoxicity dose-response curves of aminoglycosides. Antimicrobial Agents and Chemotherapy 1981; 19: 1024–1028
  • Hybels R. L. Drug toxicity of the inner ear. Medical Clinics of North America 1979; 63: 309–319
  • Jackson G. G., Arcieri G. Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States. Journal of Infectious Diseases 1971; 124: 130–137, Supplement
  • Jacobson H. R., Kokko J. P. Diuretics: sites and mechanisms of action. Annual Review of Pharmacology and Toxicology 1976; 16: 201–214
  • Jager B. V., Alway R. The treatment of acute rheumatic fever with large doses of sodium salicylate with special reference to dose management and toxic manifestations. American Journal of the Medical Sciences 1946; 211: 273–285
  • Jarvis J. F. A case of unilateral permanent deafness following acetylsalicylic acid. Journal of Laryngology and Otology 1966; 80: 318–320
  • Jobe P. C., Brown R. D. Auditory pharmacology. Trends in Pharmacological Sciences 1980; 1: 202–206
  • Johnsson L.-G., Hawkins J. E., Jr. Strial atrophy in clinical and experimental deafness. Laryngoscope 1972; 82: 1105–1125
  • Kahlmeter G., Kamme C. Prolonged excretion of gentamicin in a patient with unimpaired renal function. Lancet 1975; 1: 286
  • Kaku Y., Farmer J. C., Jr., Hudson W. R. Ototoxic drug effects on cochlear histochemistry. Archives of Otolaryngology 1973; 98: 282–286
  • Kaloyanides G. J., Pastoriza-Munoz E. Aminoglycoside nephrotoxicity. Kidney International 1980; 8: 571–582
  • Koechel D. A. Ethacrynic acid and related diuretics: relationship of structure to beneficial and detrimental actions. Annual Review of Pharmacology and Toxicology 1981; 21: 265–293
  • Komiya I., Umemura K., Fujita M., Kamiya A., Okumura K., Hori R. Mechanism of renal distribution of aminoglycoside antibiotics. Journal of Pharmacobiodynamics 1980; 3: 299–308
  • Krakoff I. H. Nephrotoxicity of c/s-dichloro-diammineplatinum (II). Cancer Treatment Reports 1979; 63: 1523–1525
  • Lawrence M. Effects of interference with terminal blood supply on organ of Corti. Laryngoscope 1966; 76: 1318–1337
  • Luft F. C. Netilmicin: a review of toxicity in laboratory animals. Journal of International Medical Research 1978; 6: 286–299
  • Maher J. E., Schreiner G. E. Studies on ethacrynic acid in patients with refractory oedema. Annals of Internal Medicine 1965; 62: 15–29
  • Mathog R. H., Klein W. J., Jr. Ototoxicity of ethacrynic acid and aminoglycoside antibiotics in uraemia. New England Journal of Medicine 1969; 280: 1223–1224
  • Mathog R. H., Thomas V. G., Hudson W. R. Ototoxicity of new and potent diuretics. Archives of Otolaryngology 1970; 92: 7–13
  • McCabe P., Dey F. The effect of aspirin upon auditory sensitivity. Annals of Otology, Rhinology and Laryngology 1965; 74: 312–324
  • McKenzie I. F. C., Mathew T. H., Bailie M. J. Peritoneal dialysis in the treatment of quinine overdose. Medical Journal of Australia 1968; 1: 58–59
  • McKinna A. J. Quinine induced hypoplasia of the optic nerve. Canadian Journal of Ophthalmology 1966; 1: 261–266
  • Meriwether W. D., Mangi R. J., Serpick A. A. Deafness following standard intravenous dose of ethacrynic acid. Journal of the American Medical Association 1971; 216: 795–798
  • Mintz U., Amir J., Pinkhas J., de Vries A. Transient perceptive deafness due to erythromycin lactobionate. Journal of the American Medical Association 1973; 225: 1122–1123
  • Morrison A. W. Personal communication cited by Ballantyne, J. (1970). Iatrogenic deafness. Journal of Laryngology and Otology 1970; 84: 967–1000
  • Myers E. N., Bernstein J. M. Salicylate ototoxicity: a clinical and experimental study. Archives of Otolaryngology 1965; 82: 483–493
  • Nordström L., Banck G., Belfrage S., Juhlin I., Tjernström Ö., Toremalm N. G. Prospective study of the ototoxicity of gentamicin. Acta Pathologica Microbiologica Scandinavica, Section B.81, Supplement 1973; 241: 54–57
  • Piel I. J., Meyer D., Perlia C. P., Wolfe V. I. Effects of c/s-diamminedichloroplatinum (NSC-1 19875) on hearing function in man. Cancer Chemotherapy Reports 1974; 58: 871–875
  • Pike D. A., Bosher S. K. The time course of the strial changes produced by intravenous furosemide. Hearing Research 1980; 3: 79–89
  • Pillay V. K. G., Schwartz F. D., Aimi K., Kark R. M. Transient and permanent deafness following treatment with ethacrynic acid in renal failure. Lancet 1969; 1: 77–79
  • Prazma J., Browder J. P., Fischer N. D. Ethacrynic acid ototoxicity potentiation by kanamycin. Annals of Otology, Rhinology and Laryngology 1974; 83: 111–118
  • Prazma J., Thomas W. G., Fischer N. D., Preslar M. J. Ototoxicity of the ethacrynic acid. Archives of Otolaryngology 1972; 95: 448–456
  • Proud G. O., Mittelman H., Seiden G. D. Ototoxicity of topically applied chloramphenicol. Archives of Otolaryngology 1968; 87: 580–587
  • Quick C. A., Hoppe W. Permanent deafness associated with furosemide administration. Annals of Otology, Rhinology and Laryngology 1975; 84: 94–101
  • Quinnan F. V., Jr., Mc Cabe W. R. Ototoxicity of erythromycin. Lancet 1978; 1: 1160–1161
  • Ransome J., Ballantyne J. C., Shaldon S., Bosher S. K., Hallpike C. S. Perceptive deafness in subjects with renal failure treated with haemodialysis and polybrene. Journal of Laryngology and Otology 1966; 80: 651–677
  • Russell N. J., Fox K. E., Brummett R. E. Ototoxic effects of the interaction between kanamycin and ethacrynic acid. Acta Otolaryngologica 1979; 88: 369–381
  • Schentag J. J., Jusko W. J., Vance J. W., Cumbo T. J., Abrutyn E., De Lattre M., Gerbracht L. M. Gentamicin disposition and tissue accumulation on multiple dosing. Journal of Pharmacokinetics and Biopharmaceutics 1977; 5: 559–577
  • Schentag J. J., Plaut M. E., Cerra F. B., Wels P. B., Walczak P., Buckley R. J. Aminoglycoside nephrotoxicity in critically ill surgical patients. Journal of Surgical Research 1979; 26: 270–279
  • Schneider W. J., Becker E. L. Acute transient hearing loss after ethacrynic acid therapy. Archives of Internal Medicine 1966; 117: 715–717
  • Schultz E. M., Cragoe E. J., Jr., Bicking J. B., Bolhofer W. A., Sprague J. A. Alpha, beta-unsaturated ketone derivatives of aryloxy-acetic acids, a new class of diuretics. Journal of Medicinal and Pharmaceutical Chemistry 1962; 5: 660–662
  • Schwartz G. H., David D. S., Riggio R. R., Stenzel K. H., Rubin A. L. Ototoxicity induced by furosemide. New England Journal of Medicine 1970; 282: 1413–1414
  • Shenoi P. M. Ototoxicity of absorbable gelatin sponge. Proceedings of the Royal Society of Medicine 1973; 66: 193–196
  • Stupp H., Rauch S., Sous H., Brun J. P., Lagler F. Kanamycin dosage and levels in ear and other organs. Archives of Otolaryngology 1967; 86: 515–521
  • Surjan L., Dévald J., Pálfalvi L. Epidemiology of hearing loss. Audiology 1973; 12: 396–410
  • Tasaki I., Davis H., Eldredge D. H. Exploration of cochlear potentials in guinea pig with a microelectrode. Journal of the Acoustical Society of America 1954; 26: 765–773
  • Thalmann R., Ise I., Bohne B. A., Thalmann I. Actions of ‘loop’ diuretics and mercurials upon the cochlea. Acta Otolaryngologica 1977; 83: 221–232
  • Thalmann R., Miyoshi T., Kusakari J., Thalmann J. Quantitative approaches to the ototoxicity problem. Audiology 1973; 12: 364–382
  • Toone E. C., Jr., Hayden G. D., Ellman H. M. Ototoxicity of chloroquine. Arthritis and Rheumatism 1965; 8: 475
  • Tsunoda Y. Ototoxicity of nitrogen mustard N-oxide. Journal of Otolaryngology of Japan 1970; 73: 581–599
  • Brazil Vital O., Prado-Franceschi J. The nature of neuromuscular block produced by neomycin and gentamicin. Archives Internationales de Pharmacodynamie et de Therapie 1969; 179: 78–85
  • Waltner J. The effect of salicylates on the inner ear. Annals of Otology, Rhinology and Laryngology 1955; 64: 617–622
  • West B. A., Brummett R. E., Himes D. L. Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pgs. Archives of Otolaryngology 1973; 98: 32–37
  • Winkel O., Hansen M. M., Kaaber K., Rozarth K. A prospective study of gentamicin ototoxicity. Acta Otolaryngologica 1978; 86: 212–216

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.